Theoretical and technological foundations of neuropeptidomics (review)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Adaptation of the human body to the changing factors of the internal and external environment is impossible without the normal regulation of the activity of organs and systems. Neuropeptides - biologically active compounds, the synthesis of which occurs mainly in the cells of the central nervous system, play a decisive role in the mechanisms of memory, learning, sleep, regulate metabolic processes, maintain homeostasis. These compounds are used as drugs - neuroprotective agents for neurodegeneration. The analysis of domestic and foreign literature containing information on the current state and development prospects of neuropepti-domics, focused on the study of the spectrum of brain peptides in normal and pathological conditions. Neuropeptides are regulators of the functional activity of central nervous system cells in normal and pathological conditions, actively participating in the pathogenesis of developmental disorders, ischemic and traumatic brain damage, and chronic neurodegeneration. The authors consider the possibility of using modifications of various analytical methods (chromatographic, mass spectrometric and chromato-mass spectrometric) and their combinations in biomedical research and in the search for biomarkers. Peptidomics provides information on low-mass proteins and products of proteolytic degradation of proteins. Neuropeptides have selective permeability through the blood-brain barrier, therefore, a complex of peptides can serve as an indicator of pathological processes and can be used as markers of the early stages of the disease or mediators of pathological processes. Of the many sensitive and specific methods for studying neuropeptides, mass spectrometry is becoming the leading technology in peptidomics. This platform is ideal for analysis of drug metabolism, therapeutic monitoring of drugs, proteomics, metabolomics, analysis of environmental objects, food products, toxicology and clinical applications. Thus, one of the most important applied goals of neuropeptidomics is the laboratory diagnosis of new biomarkers with ultra-sensitivity, high specificity and prognostic value for creating new diagnostic algorithms and for assessing the risk of developing a disease in the context of preventive personalized medicine.

Full Text

Restricted Access

About the authors

E. A Teplyashina

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: elenateplyashina@mail.ru
Ph.D. (Biol.), Associate Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry

R. Ya Olovyannikova

Ph.D. (Biol.)

E. V Kharitonova

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: ekaterinavl201@gmail.com
Ph.D. (Pharm.), Senior Lecturer, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry

O. L Lopatina

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: ol.lopatina@gmail.com
Dr.Sc. (Biol.), Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry

V. A Kutyakov

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: victor-koutjakov@yandex.ru
Ph.D. (Biol.), Associate Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry

S. I Pashchenko

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: psi51@mail.ru
Assistant, Department of Biological Chemistry with a course in medical, pharmaceutical and toxicological chemistry

E. A Pozhilenkova

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: elena.a.pozhilenkova@gmail.com
Ph.D. (Biol.), Associate Professor, Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry

A. B Salmina

Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky

Email: allasalmina@mail.ru
Dr.Sc. (Med.), Professor, Head of the Department of Biological Chemistry with a Course in Medical, Pharmaceutical and Toxicological Chemistry

References

  1. Кутяков В.А., Харитонова Е.В., Оловянникова Р.Я., Салмина А.Б. Современное состояние и перспективы применения методов протеомики в химико-токсикологическом анализе (обзор). Вопросы биологической, медицинской и фармацевтической химии. 2019; 22(9): 47-52.
  2. Говорун В.М., Иванов В.Т. Протеомика и пептидомика в фундаментальных и прикладных медицинских исследованиях. Биоорганическая химия. 2011; 37(2): 199-215.
  3. Li L., Sweedler J. V. Peptides in the brain: mass spectrometry-based measurement approaches and challenges. Annu. Rev. Anal. Chem. 2008; 1: 451-483.
  4. Nykmder I., Stenfors C., Tan-No K, Mathe A.A., Terenius LA. Comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides. Neuropeptides. 1997; 31: 357-365.
  5. Che F.Y., Lim J., Pan H., Biswas R., Flicker L.D. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol. Cell Proteomics. 2005; 4: 1391-1405.
  6. Che F.Y., Fricker L.D. Quantitative peptidomics of mouse pituitary: comparison of 32. different stable isotopic tags. J. Mass. Spectrom. 2005; 40: 238-249.
  7. Svensson M, Boren М., Skold K., Faith M, Sjogren B., Andersson M, Svenningsson P., Andren P.E. Heat stabilization of the tissue proteome: a new technology for improved proteomics. J. Proteome. Res. 2009; 8: 974-981.
  8. Чугунов A.O. Неизвестные пептиды: «теневая» система биорегуляции. Наука и жизнь. 2010; 26-31.
  9. Schrader М., Fricker L. Peptidomics: Methods and Strategies. Methods in Molecular Biology. 1-st ed. Springer, Berlin. 2018.423 p.
  10. DeLaney K., Buchberger A.R., Atkinson L., Grander S., Mousley A., Li L. New techniques, applications and perspectives in neuropeptide research. Journal of Experimental Biology. 2018. 221 p.
  11. Muth Т., Keller D., Puetz S.M., Martens L., Sickmann A., Boehm A.M. jTraqX: a Free, Platform Independent Tool for Isobaric Tag Quantitation at the Protein Level. Proteomics. 2010; 10(6): 1223-1225.
  12. Dallas D.C., Guerrero A., Parker E.A., Robinson R.C., Gan J., German J.B., Barile D., Lebrilla C.B. Current peptidomics: Applications, purification, identification, quantification, and functional analysis. Proteomics. 2015; 15(0): 1026-1038.
  13. Hook V, Lietz C., Podvin S., Cajka Т., Fiehn O. Diversity of Neuropeptide Cell-Cell Signaling Molecules Generated by Proteolytic Processing Revealed by Neuropeptidomics Mass Spectrometry. J. Am. Soc. Mass. Spectrom. 2018; 29(5): 807-816.
  14. Yin P., Нои X., Romanova E.V., Sweedler J.V. Neuropeptidomics: Mass Spectrometry-Based Qualitative and Quantitative Analysis. Methods in Molecular Biology. 2011; 789: 223-236.
  15. Чечеткин B.P., Прокопенко Д.В., Макаров A.A., Заседателев А.С. Биочипы для медицинской диагностики. Российские нанотехнологии. 2006; 1(1-2): 13-18.
  16. Терентьев А.А., Молдогазиева Н.Т., Шайтан К.В. Динамическая протеомика в моделировании живой клетки. Белок-белковые взаимодействия. Успехи биологической химии. 2009; 49: 429-480.
  17. Secher A., Kelstrup C.D., Conde-Frieboes K.W., Руке С., Raun К, Wulff B.S., Olsen J.V. Analytic framework for peptidomics applied to large-scale neuropeptide identification. Nat. Commun. 2016; 7: 11436.
  18. Romanova E. V, Sweedler J. V. Peptidomics for the discovery and characterization of neuropeptides and hormones. Trends in Pharmacological Sciences. 2015; 36(9): 579-585.
  19. GoodlettD.R., Keller A., Watts J.D., Keller A., Newitt R. Differential stable isotope labeling of peptides for quantitation and de novo sequence derivation Rapid Commun. Mass Spectrom. 2001; 15: 1214-1221.
  20. Kinter М., Sherman N.E. Protein sequencing and identification using tandem mass spectrometry. John Wiley & Sons, Inc. New York. 2000.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies